Nephros Inc. NEPH
4.23
0.09
2.17%
as of 25 Sep
- Market cap
- $45.0M
- P/E
- 27.2×
Follow NEPH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
16.29% | 12.71% | 7.76% | 16.10% | |
| 12.53% | 9.61% | 6.07% | 12.39% | ||
ROIC |
18.68% | 14.92% | 6.33% | 14.11% | |
Return on Tangible Assets |
17.72% | 13.95% | 8.56% | 16.80% | |
Average Days of Receivables |
54.17 | 46.90 | 67.20 | 72.15 | |
Free Cash Flow per Share |
0.26 | 0.16 | (0.03) | (0.06) | |
Free Cash Flow |
2.72 | 1.65 | (0.35) | (0.66) | |
Piotroski F-Score |
6.00 | 6.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
17.92% | 10.54% | (2.36%) | (3.97%) | |
Accounts Receivable Turnover |
8.24 | 8.96 | 6.17 | 6.75 | |
Accounts Payable Turnover |
9.88 | 9.17 | 7.58 | 6.18 | |
Inventory Turnover |
2.26 | 2.45 | 2.75 | 2.37 | |
Average Days of Payables |
51.83 | 46.57 | 69.71 | 89.35 | |
Days of Inventory on Hand |
151.63 | 164.67 | 172.45 | 206.76 | |
Tax Rate |
(0.01) | 0.00 | 0.00 | (0.01) | |
Research and Development Expense of Revenue |
6.67% | 7.13% | 7.27% | 6.97% | |
Selling, General and Administrative Expense of Revenue |
47.72% | 47.90% | 48.46% | 45.77% | |
Share Based Compensation of Revenue |
1.56% | 1.58% | 1.46% | 1.30% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.84 | 1.38 | (0.45) | (0.38) | |
Depreciation/Fixed assets |
1.19 | 1.31 | 1.33 | 1.46 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
1.69 | 1.77 | 1.80 | 1.91 | |
Operating CF per Share |
0.26 | 0.16 | (0.03) | (0.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
8.26% | 6.35% | 4.06% | 8.38% |
Columns are period end dates